You have access
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study
JUN YAMAMURA, SHUNJI KAMIGAKI, MASAKI TSUJIE, JUNYA FUJITA, HIROKI OSATO, CHIHIRO HIGASHI, HIROFUMI KANAIZUMI, YUMIKO TANAKA, MIKA HAMADA, WATARU SHINZAKI, YUKIHIKO HASHIMOTO and YOSHIFUMI KOMOIKE
In Vivo January 2019, 33 (1) 281-287; DOI: https://doi.org/10.21873/invivo.11473
